Oluf Dimitri Røe
Oluf Dimitri Røe
MD PhD NTNU, Norway
Verifierad e-postadress på ntnu.no
Citeras av
Citeras av
Shortlasting unilateral neuralgiform headache attacks with conjunctival injection, tearing, sweating, and rhinorrhea.
O Sjaastad, C Saunte, R Salvesen, TA Fredriksen, A Seim, OD Røe, ...
Cephalalgia 9 (2), 147-56, 1989
Malignant pleural mesothelioma: history, controversy, and future of a man-made epidemic
OD Røe, GM Stella
Asbestos and Mesothelioma, 73-101, 2017
Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma
V Panou, M Gadiraju, A Wolin, CM Weipert, E Skarda, AN Husain, ...
Journal of Clinical Oncology 36 (28), 2863, 2018
CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer
S Wang, X Wu, J Zhang, Y Chen, J Xu, X Xia, S He, F Qiang, A Li, Y Shu, ...
Gut 62 (4), 496-508, 2013
Prognostic and predictive role of JWA and XRCC1 expressions in gastric cancer
S Wang, X Wu, Y Chen, J Zhang, J Ding, Y Zhou, S He, Y Tan, F Qiang, ...
Clinical cancer research 18 (10), 2987-2996, 2012
The established and future biomarkers of malignant pleural mesothelioma
V Panou, M Vyberg, UM Weinreich, C Meristoudis, UG Falkmer, OD Røe
Cancer treatment reviews 41 (6), 486-495, 2015
Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype
OD Røe, E Anderssen, E Helge, CH Pettersen, KS Olsen, H Sandeck, ...
PloS one 4 (8), e6554, 2009
Malignant pleural mesothelioma: genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets
OD Røe, E Anderssen, H Sandeck, T Christensen, E Larsson, S Lundgren
Lung cancer 67 (1), 57-68, 2010
TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer
W Xu, S Wang, Q Chen, Y Zhang, P Ni, X Wu, J Zhang, F Qiang, A Li, ...
Cell death & disease 5 (2), e1055-e1055, 2014
Mesothelin-related predictive and prognostic factors in malignant mesothelioma: a nested case–control study
OD Roe, J Creaney, S Lundgren, E Larsson, H Sandeck, P Boffetta, ...
Lung Cancer 61 (2), 235-243, 2008
Absence of SV40 antibodies or DNA fragments in prediagnostic mesothelioma serum samples
K Kjærheim, OD Røe, T Waterboer, P Sehr, R Rizk, HY Dai, H Sandeck, ...
International journal of cancer 120 (11), 2459-2465, 2007
JWA suppresses tumor angiogenesis via Sp1-activated matrix metalloproteinase-2 and its prognostic significance in human gastric cancer
Y Chen, Y Huang, Y Huang, X Xia, J Zhang, Y Zhou, Y Tan, S He, F Qiang, ...
Carcinogenesis 35 (2), 442-451, 2014
Gefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: a systematic review
X Chen, Y Liu, OD Røe, Y Qian, R Guo, L Zhu, Y Yin, Y Shu
PloS one 8 (3), e59314, 2013
JWA reverses cisplatin resistance via the CK2—XRCC1 pathway in human gastric cancer cells
W Xu, Q Chen, Q Wang, Y Sun, S Wang, A Li, S Xu, OD Røe, M Wang, ...
Cell death & disease 5 (12), e1551-e1551, 2014
WT1 promotes cell proliferation in non-small cell lung cancer cell lines through up-regulating cyclin D1 and p-pRb in vitro and in vivo
C Xu, C Wu, Y Xia, Z Zhong, X Liu, J Xu, F Cui, B Chen, OD Røe, A Li, ...
PLoS One 8 (8), e68837, 2013
Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry
HP Sandeck, OD Røe, K Kjærheim, H Willén, E Larsson
Diagnostic pathology 5, 1-15, 2010
A validated clinical risk prediction model for lung cancer in smokers of all ages and exposure types: a HUNT study
M Markaki, I Tsamardinos, A Langhammer, V Lagani, K Hveem, OD Røe
EBioMedicine 31, 36-46, 2018
Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer
X Chen, X Zha, W Chen, T Zhu, J Qiu, OD Røe, J Li, Z Wang, Y Yin
Biomedicine & Pharmacotherapy 67 (1), 22-30, 2013
Molecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesothelioma
OD Røe, A Szulkin, E Anderssen, A Flatberg, H Sandeck, T Amundsen, ...
Public Library of Science 7 (8), e40521, 2012
Dysregulated atrial gene expression of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand axis in the development and progression of atrial fibrillation
H Cao, J Wang, L Xi, OD Røe, Y Chen, D Wang
Circulation Journal 75 (12), 2781-2788, 2011
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20